synthetic oligonucleotides
Molecular Assemblies Extends Series A Financing Round by $11.8M
The enzymatic DNA synthesis company added money from new and existing investors to a 2019 $12.2 million Series A round led by iSelect Fund.
Piper Sandler Initiates Coverage of Twist Bioscience, Codexis With Overweight Ratings
The investment bank said it believes Twist's high growth is "sustainable" and that synthetic biology is the most exciting market in the life sciences sector.
The Syntax instrument, available later this year, will initially be able to make batches of 96 oligos of 60-mer length at a time with same-day turnaround.
DNA Script Exclusively Licenses Modified DNA Printing Technology From Baseclick
The Paris-based company plans to use the nucleic acid modification technology to synthesize qPCR probes for use in diagnostics, among other biomolecules.
Twist Bioscience, Berry Genomics Partner on Targeted NGS Assays in China
The companies will work together to develop new next-generation sequencing-based panels for research and diagnostics of inherited diseases.
Feb 5, 2021
Dec 2, 2020
Twist Bioscience Proposes $250M Public Offering
Nov 23, 2020
Nov 23, 2020
Twist Bioscience Fiscal Q4 Revenues More Than Double
Aug 6, 2020
Twist Bioscience Q3 Revenues Grow 56 Percent
Jun 4, 2020
Twist Bioscience Prices $100M Stock Offering
May 7, 2020
Twist Bioscience Q2 Revenues Increase 42 Percent
Mar 2, 2020
Evonetix Closes £23M Series B Financing
Jan 15, 2020
IARPA Commits $48M to DNA Data Storage
Dec 12, 2019